X4 Pharmaceuticals XFOR
NASDAQ XFOR
$2.75 -0.08 (-2.83%)
As of: Oct 2, 2026 · 1:48 PM EDT

X4 Pharmaceuticals (XFOR) Depreciation & Amortization (CF) (2017 - 2026)

Updated

X4 Pharmaceuticals' Depreciation & Amortization (CF) came in at $997,000 for Q2 2026, up 180.8% from $355,000 a year earlier and up 347.1% from the prior quarter.

Analysis

X4 Pharmaceuticals (XFOR) Depreciation & Amortization (CF) (2017 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, X4 Pharmaceuticals reported Depreciation & Amortization (CF) of $1.67 million, up 21.5% year-over-year; for FY2025, it was $1.28 million, up 60.4% from FY2024.

  • Depreciation & Amortization (CF) carries a five-year compound annual growth rate of 29.5% (FY2020 to FY2025).
  • Going back by year, Depreciation & Amortization (CF) was $796,000 in FY2024 (+90.0%), $419,000 in FY2023 (-18.3%), $513,000 in FY2022 (+2.8%) and $499,000 in FY2021 (+42.2%).
  • The Q2 2026 figure represents the highest quarterly Depreciation & Amortization (CF) in data going back to Q1 2017.
  • Year-over-year, Depreciation & Amortization (CF) increased in five of the last eight quarters, with growth averaging 167.6%.
  • The fastest year-over-year change in Depreciation & Amortization (CF) over five years came in Q1 2025 (growth of 667.7%), and the weakest in Q1 2026 (a decline of 53.2%).
  • Business Quant data shows XFOR's Depreciation & Amortization (CF) at $223,000 (Q1 2026), $223,000 (Q4 2025) and $223,000 (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 X4 Pharmaceuticals 366.40 Mn -332.29 Mn 7.19 Mn 997,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 997,000.00
Mar 31, 2026 223,000.00
Dec 31, 2025 223,000.00
Sep 30, 2025 223,000.00
Jun 30, 2025 355,000.00
Mar 31, 2025 476,000.00
Dec 31, 2024 273,000.00
Sep 30, 2024 267,000.00
Jun 30, 2024 194,000.00
Mar 31, 2024 62,000.00
Dec 31, 2023 62,000.00
Sep 30, 2023 104,000.00
Jun 30, 2023 126,000.00
Mar 31, 2023 127,000.00
Dec 31, 2022 124,000.00
Sep 30, 2022 124,000.00
Jun 30, 2022 132,000.00
Mar 31, 2022 133,000.00
Dec 31, 2021 132,000.00
Sep 30, 2021 132,000.00
API Access

X4 Pharmaceuticals Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=XFOR&period=max&api_key=YOUR_API_KEY